Combination therapy offers breakthrough in NSCLC treatment

A specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung cancer (NSCLC) overcome inherent immune resistance and reinvigorate anti-tumor activity, according to a new study led by a researcher from The University of Texas MD Anderson Cancer Center.

Immunotherapy breakthrough: Pembrolizumab extends time to recurrence in aggressive bladder cancer

Patients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have a new treatment option.

January 27, 2024

Revolutionizing liver transplants in pigs with magnetic anastomosis technology

The effectiveness of magnetic anastomosis technology (MAT) in Liver Transplantation.

November 21, 2023

Editorial: Health studies cast shadow on weed – The Cannabist

Massachusetts has often been described as a nanny state, cosseting its citizens with overprotective policies. But sometimes the nanny takes a day off. The commonwealth

May 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.